Tag Archives: merger

API to buy out Sigma

Australian Pharmaceutical Industries Limited (API) acquires 100 per cent of the shares in Sigma, via a scheme of arrangement (scheme). Under that proposal Sigma’s shareholders would receive 0.31 API shares and $0.23 cash for each Sigma share. Based on the terms of the API proposal and the API share price …

Read More »

ACCC clears merger

The Australian Competition and Consumer Commission has decided not to oppose the merger of generic pharmaceutical companies, Arrow and Apotex after finding the transaction “would not substantially lessen competition in any market”. In May 2018, Strides Pharma Science and Apotex announced their intention to merge Arrow Pharmaceuticals and Apotex Australia …

Read More »